These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

453 related articles for article (PubMed ID: 24620626)

  • 41. Small intestinal bacterial overgrowth in patients suffering from scleroderma: clinical effectiveness of its eradication.
    Parodi A; Sessarego M; Greco A; Bazzica M; Filaci G; Setti M; Savarino E; Indiveri F; Savarino V; Ghio M
    Am J Gastroenterol; 2008 May; 103(5):1257-62. PubMed ID: 18422815
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Hydrogen sulphide in exhaled breath: a potential biomarker for small intestinal bacterial overgrowth in IBS.
    Banik GD; De A; Som S; Jana S; Daschakraborty SB; Chaudhuri S; Pradhan M
    J Breath Res; 2016 May; 10(2):026010. PubMed ID: 27163246
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Small intestinal bacterial overgrowth in patients with interstitial cystitis and gastrointestinal symptoms.
    Weinstock LB; Klutke CG; Lin HC
    Dig Dis Sci; 2008 May; 53(5):1246-51. PubMed ID: 17932763
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Preferential usage of rifaximin for the treatment of hydrogen-positive smallintestinal bacterial overgrowth.
    Barkin JA; Keihanian T; Barkin JS; Antequera CM; Moshiree B
    Rev Gastroenterol Peru; 2019; 39(2):111-115. PubMed ID: 31333225
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A combination of rifaximin and neomycin is most effective in treating irritable bowel syndrome patients with methane on lactulose breath test.
    Low K; Hwang L; Hua J; Zhu A; Morales W; Pimentel M
    J Clin Gastroenterol; 2010 Sep; 44(8):547-50. PubMed ID: 19996983
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Rifaximin versus other antibiotics in the primary treatment and retreatment of bacterial overgrowth in IBS.
    Yang J; Lee HR; Low K; Chatterjee S; Pimentel M
    Dig Dis Sci; 2008 Jan; 53(1):169-74. PubMed ID: 17520365
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Abnormal breath tests to lactose, fructose and sorbitol in irritable bowel syndrome may be explained by small intestinal bacterial overgrowth.
    Nucera G; Gabrielli M; Lupascu A; Lauritano EC; Santoliquido A; Cremonini F; Cammarota G; Tondi P; Pola P; Gasbarrini G; Gasbarrini A
    Aliment Pharmacol Ther; 2005 Jun; 21(11):1391-5. PubMed ID: 15932370
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Breath Testing for Small Intestinal Bacterial Overgrowth: A Means to Enrich Rifaximin Responders in IBS Patients?
    Gupta A; Chey WD
    Am J Gastroenterol; 2016 Mar; 111(3):305-6. PubMed ID: 26925880
    [No Abstract]   [Full Text] [Related]  

  • 49. [Rifaximin application in the overgrowth bacterial syndrome in the small intestine in patients after cholecystectomy].
    Mechetina TA; Il'chenko AA; Lychkova AE
    Eksp Klin Gastroenterol; 2011; (3):93-100. PubMed ID: 21695956
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [The dietary features of diarrhea predominant irritable bowel syndrome patients with small intestinal bowel overgrowth].
    Wei H; Liu ZJ; Wang K; Zheng W; Duan LP
    Zhonghua Nei Ke Za Zhi; 2017 Aug; 56(8):567-571. PubMed ID: 28789488
    [No Abstract]   [Full Text] [Related]  

  • 51. Small intestinal bacterial overgrowth is associated with Diarrhea-predominant irritable bowel syndrome by increasing mainly
    Wu KQ; Sun WJ; Li N; Chen YQ; Wei YL; Chen DF
    Scand J Gastroenterol; 2019 Dec; 54(12):1419-1425. PubMed ID: 31765575
    [No Abstract]   [Full Text] [Related]  

  • 52. Clinical value of radionuclide small intestine transit time measurement combined with lactulose hydrogen breath test for the diagnosis of bacterial overgrowth in irritable bowel syndrome.
    Ning Y; Lou C; Huang Z; Chen D; Huang H; Chen L; Zhang B; Dai N; Zhao J; Zhen X
    Hell J Nucl Med; 2016; 19(2):124-9. PubMed ID: 27331205
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Duodenal and rectal mucosal microbiota related to small intestinal bacterial overgrowth in diarrhea-predominant irritable bowel syndrome.
    Yang M; Zhang L; Hong G; Li Y; Li G; Qian W; Xiong H; Bai T; Song J; Hou X
    J Gastroenterol Hepatol; 2020 May; 35(5):795-805. PubMed ID: 31674052
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Prevalence and predictors of small intestinal bacterial overgrowth in irritable bowel syndrome: a systematic review and meta-analysis.
    Chen B; Kim JJ; Zhang Y; Du L; Dai N
    J Gastroenterol; 2018 Jul; 53(7):807-818. PubMed ID: 29761234
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Bacterial concepts in irritable bowel syndrome.
    Lin HC; Pimentel M
    Rev Gastroenterol Disord; 2005; 5 Suppl 3():S3-9. PubMed ID: 17713456
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Breath test for differential diagnosis between small intestinal bacterial overgrowth and irritable bowel disease: an observation on non-absorbable antibiotics.
    Esposito I; de Leone A; Di Gregorio G; Giaquinto S; de Magistris L; Ferrieri A; Riegler G
    World J Gastroenterol; 2007 Dec; 13(45):6016-21. PubMed ID: 18023092
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Small intestinal bacterial overgrowth and lactose intolerance contribute to irritable bowel syndrome symptomatology in Pakistan.
    Yakoob J; Abbas Z; Khan R; Hamid S; Awan S; Jafri W
    Saudi J Gastroenterol; 2011; 17(6):371-5. PubMed ID: 22064333
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Small intestine bacterial overgrowth in patients with irritable bowel syndrome.
    Carrara M; Desideri S; Azzurro M; Bulighin GM; Di Piramo D; Lomonaco L; Adamo S
    Eur Rev Med Pharmacol Sci; 2008; 12(3):197-202. PubMed ID: 18700692
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Eradication of small intestinal bacterial overgrowth reduces symptoms of irritable bowel syndrome.
    Pimentel M; Chow EJ; Lin HC
    Am J Gastroenterol; 2000 Dec; 95(12):3503-6. PubMed ID: 11151884
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Study of small intestinal bacterial overgrowth in North Indian patients with irritable bowel syndrome: a case control study.
    Rana SV; Sinha SK; Sikander A; Bhasin DK; Singh K
    Trop Gastroenterol; 2008; 29(1):23-5. PubMed ID: 18564663
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.